| Bioactivity | Thymalfasin is an immunomodulating agent able to enhance the Thl immune response. | ||||||
| Invitro | Thymalfasin has been shown to have efficacy in multiple experimental models of immune dysfunction, mainly, infectious diseases such as hepatitis (woodchuck) and influenza (mouse), and cancer such as melanoma (mouse) and colorectal carcinoma (rat) where thymalfasin has shown antitumor effects[2]. | ||||||
| Name | Thymalfasin | ||||||
| CAS | 62304-98-7 | ||||||
| Sequence | N-acetyl-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn | ||||||
| Shortening | Ac-SDAAVDTSSEITTKDLKEKKEVVEEAEN | ||||||
| Formula | C129H215N33O55 | ||||||
| Molar Mass | 3108.28 | ||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||
| Storage | Sealed storage, away from moisture
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |